Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,967 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy

NCT01485991

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Bakersfield, California, United States
  • San Diego, California, United States
  • Aurora, Colorado, United States
  • Washington D.C., District of Columbia, United States
View all 137 locations
View Trial Details
Completed

Study of a New MVA Vaccine for Hepatitis C Virus

NCT01296451

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom
  • John Radcliffe Hospital, Headley Way Headington, Oxford, United Kingdom
  • Wycombe Hospital, High Wycombe, Buckinghamshire High Wycombe, United Kingdom
View Trial Details
Completed

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

NCT01970904

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Cologne, Germany
  • Novartis Investigative Site Düsseldorf, Germany
View all 25 locations
View Trial Details
Completed

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

NCT00905632

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1241.7.3307A CHU de Grenoble Grenoble Cédex 9, France
  • 1241.7.3303A Hôpital Claude Huriez Lille, France
  • 1241.7.3302A Hopital de l'Hotel Dieu Lyon, France
  • 1241.7.3301A Hôpital Saint Eloi Montpellier, France
View all 18 locations
View Trial Details
Completed

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

NCT01732796

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1241.20.00026 Boehringer Ingelheim Investigational Site Dothan, Alabama, United States
  • 1241.20.00033 Boehringer Ingelheim Investigational Site Chula Vista, California, United States
  • 1241.20.00006 Boehringer Ingelheim Investigational Site La Mesa, California, United States
  • 1241.20.00003 Boehringer Ingelheim Investigational Site Oceanside, California, United States
View all 101 locations
View Trial Details
Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

NCT00077649

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • La Jolla, California, United States
  • Long Beach, California, United States
  • San Diego, California, United States
  • San Diego, California, United States
View all 25 locations
View Trial Details

Related conditions